言語を選択

CD30 ligand

CD30 ligand 詳細

英語名	Tumor necrosis factor ligand superfamily member 8	市販薬剤の数	0
治験薬の数	0	ターゲットの別称	CD153，CD30LG，CD30 ligand，CD30-L，CD30L，Tumor Necrosis Factor (Ligand) Superfamily， Member 8，TNF Superfamily Member 8，Tumor Necrosis Factor Ligand Superfamily Member 8，TNLG3A，CD153 Antigen，Tumor Necrosis Factor Superfamily Member 8，Tumor Necrosis Factor Ligand 3A，CD30 Antigen Ligand
研究＆開発段階	Preclinical

英語名	Tumor necrosis factor ligand superfamily member 8
ターゲットの別称	CD153，CD30LG，CD30 ligand，CD30-L，CD30L，Tumor Necrosis Factor (Ligand) Superfamily， Member 8，TNF Superfamily Member 8，Tumor Necrosis Factor Ligand Superfamily Member 8，TNLG3A，CD153 Antigen，Tumor Necrosis Factor Superfamily Member 8，Tumor Necrosis Factor Ligand 3A，CD30 Antigen Ligand
市販薬剤の数	0
治験薬の数	0
研究＆開発段階	Preclinical

CD30 ligand 製品リスト

属性
Protein (2)
製品ライブラリ
オンライン (2)
種
Human (2)
タグ
Mouse IgG Fc Tag (1)His Tag (1)
マーカー
Unconjugated (2)

製品番号	種	発現システム	製品説明	タンパク質の構造	純度	特性
CDL-H524b	Human	HEK293	Human CD30 Ligand / TNFSF8 Protein, His Tag, low endotoxin (MALS verified)
CDL-H525b	Human	HEK293	Human CD30 Ligand / TNFSF8 Protein, Mouse IgG2a Fc Tag, low endotoxin

総数量2

CD30 ligandバックグランド

CD30 ligand (CD30L) and CD30 are interacting cellsurface glycoproteins that are members of the tumour necrosis factor (TNF) and tumour necrosis factor receptor (TNFR) superfamilies. In humans, CD30L is expressed at high levels on activated T cells. There is conflicting evidence with regard to cell surface expression of CD30L on primary human B cells. An initial report of constitutive CD30L expression on peripheral blood B cells33 has not been substantiated.